Reyes-Resina Irene, Aguinaga David, Labandeira-García José Luis, Lanciego José Luis, Navarro Gemma, Franco Rafael
Department of Biochemistry and Molecular Biomedicine, School of Biology, Universitat de Barcelona, Barcelona, Spain.
Centro de Investigación en Red, Enfermedades Neurodegenerativas (CIBERNED), Instituto de Salud Carlos III, Madrid, Spain.
Histol Histopathol. 2018 Sep;33(9):909-917. doi: 10.14670/HH-11-963. Epub 2018 Jan 16.
Immunochemical detection of G-protein-coupled receptors (GPCRs) in cells and tissues was a technical challenge for years. After the discovery of formation of GPCR dimers/trimers/tetramers in transfected cells, a most recent challenge has been to confirm receptor-receptor interactions in natural sources. The occurrence of dimers or higher order oligomers is important from a therapeutic point of view, mainly because their physiology/pharmacology is different from those of individual receptors. On the one hand, pathophysiological factors need to count more on GPCR dimers than on individual receptors. On the other hand, the expression of dimers, trimers, etc. may change in pathological conditions and/or along the course of a disease. This review will focus on G-protein-coupled receptor dimers, on how to detect them by novel histological techniques and on how the detection may be used in diagnosis and therapy of ailments of the central nervous system, for instance in neurodegenerative diseases and gliomas.
多年来,在细胞和组织中对G蛋白偶联受体(GPCRs)进行免疫化学检测一直是一项技术挑战。在转染细胞中发现GPCR二聚体/三聚体/四聚体的形成后,最近的一项挑战是在天然来源中确认受体-受体相互作用。从治疗角度来看,二聚体或更高阶寡聚体的出现很重要,主要是因为它们的生理学/药理学与单个受体不同。一方面,病理生理因素在GPCR二聚体上比在单个受体上需要更多考量。另一方面,二聚体、三聚体等的表达在病理状况下和/或疾病过程中可能会发生变化。本综述将聚焦于G蛋白偶联受体二聚体,如何通过新型组织学技术检测它们,以及这种检测如何用于中枢神经系统疾病的诊断和治疗,例如神经退行性疾病和神经胶质瘤。